- Home
- HUHU vs ANVS Comparison
HUHU vs ANVS Comparison
Compare HUHU & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUHU
- ANVS
- Stock Information
- Founded
- HUHU 2015
- ANVS 2008
- Country
- HUHU China
- ANVS United States
- Employees
- HUHU N/A
- ANVS N/A
- Industry
- HUHU
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- HUHU
- ANVS Health Care
- Exchange
- HUHU NYSE
- ANVS Nasdaq
- Market Cap
- HUHU 86.2M
- ANVS 92.6M
- IPO Year
- HUHU 2024
- ANVS 2020
- Fundamental
- Price
- HUHU $4.23
- ANVS $2.13
- Analyst Decision
- HUHU
- ANVS Strong Buy
- Analyst Count
- HUHU 0
- ANVS 6
- Target Price
- HUHU N/A
- ANVS $31.40
- AVG Volume (30 Days)
- HUHU 21.4K
- ANVS 684.1K
- Earning Date
- HUHU 02-22-2025
- ANVS 03-31-2025
- Dividend Yield
- HUHU N/A
- ANVS N/A
- EPS Growth
- HUHU 13.14
- ANVS N/A
- EPS
- HUHU 0.08
- ANVS N/A
- Revenue
- HUHU $17,492,735.00
- ANVS N/A
- Revenue This Year
- HUHU N/A
- ANVS N/A
- Revenue Next Year
- HUHU N/A
- ANVS N/A
- P/E Ratio
- HUHU $51.35
- ANVS N/A
- Revenue Growth
- HUHU 33.03
- ANVS N/A
- 52 Week Low
- HUHU $2.97
- ANVS $2.08
- 52 Week High
- HUHU $9.89
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- HUHU N/A
- ANVS 18.43
- Support Level
- HUHU N/A
- ANVS $2.08
- Resistance Level
- HUHU N/A
- ANVS $2.79
- Average True Range (ATR)
- HUHU 0.00
- ANVS 0.32
- MACD
- HUHU 0.00
- ANVS -0.06
- Stochastic Oscillator
- HUHU 0.00
- ANVS 2.08
About HUHU HUHUTECH INTL GROUP INC
HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.